Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06864819

Role of Phosphatidylethanol in Predicting Perioperative Outcomes of Admitted Patients at UHCMC

Status
Recruiting
Phase
Study type
Observational
Enrollment
170 (estimated)
Sponsor
University Hospitals Cleveland Medical Center · Academic / Other
Sex
All
Age
21 Years – 79 Years
Healthy volunteers
Not accepted

Summary

This study aims to see if there's a link between a substance called phosphatidylethanol (PEth) and how patients who have surgery at University Hospitals do after surgery. PEth levels reflect the amount of alcohol use by someone over the past few weeks. This study is checking PEth levels on all patients who are planned to stay in the hospital for three or more days after surgery regardless if they drink alcohol. Specifically, it will look at if PEth levels are connected to problems that might come up during and after surgery, like confusion, lung or heart issues, needing blood transfusions, infections, unexpected intensive care unit (ICU) stays, and longer hospital stays. While there are reports of moderate alcohol consumption being good for the heart, there are other data that alcohol consumption can be harmful. Since there's not much information on how drinking alcohol affects health outcomes during and after surgery, especially for patients who are planned to be admitted to the hospital ward or ICU after surgery, this study will hopefully see if PEth levels before surgery can predict how patients do after the surgery. The inclusion criteria to only include patients who consume alcoholic beverages was an IRB approved modification after already recruiting 1/3 of patients.

Conditions

Interventions

TypeNameDescription
OTHERBlood DrawPatients will have a single blood sample sent for PEth testing, blood draws will happen during standard of care blood draw.

Timeline

Start date
2025-05-05
Primary completion
2026-08-01
Completion
2026-08-01
First posted
2025-03-07
Last updated
2026-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06864819. Inclusion in this directory is not an endorsement.